pharma · Solid Tumor, Adult · Solid Tumor · CTMX
CytomX Therapeutics
CytomX Therapeutics is a pharma organization headquartered in South San Francisco, USA. It trades on NYSE under ticker CTMX. Primary therapeutic focus areas include Solid Tumor, Adult, Solid Tumor, Neoplasms, Solid Tumor
South San Francisco, USA HQ
98 Employees
Public company Type
CTMX · NYSE Ticker
Company details
- Status
- Public
- HQ
- South San Francisco, USA
- Employees
- 98
- Programs
- 8
- Drugs
- 0
- Patents
- 62
CX-904
Phase 1 · small molecule · Solid Tumors
CX-904 for Solid Tumors is a Phase 1 program (small_molecule) at CytomX Therapeutics with 1 ClinicalTrials.gov record(s).
Internal code CTMX-904-101
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- CytomX Therapeutics
- Phase
- Phase 1
- Modality
- small_molecule
- Indication
- Solid Tumors
- Status
- terminated
- Trials
- 1